Earnings Coupang (CPNG) Reports Loss for Q4 FY25, Misses Estimates; Revenue at $8.84B 6 days ago Coupang missed Q4 EPS estimates by $0.05 per share despite revenue topping consensus, as infrastructure investments pressured margins. GDS Holdings Limited Reports Q4 2025 Results 6 days ago GDS Holdings Limited (GDS) reported Q4 2025 GAAP earnings of -$0.62 per share, missing the $12.31 consensus estimate (miss by… Elbit Systems (ESLT) Crushes Q4 Estimates with $3.56 EPS, Revenue Surges 11.3% to $2.15B 6 days ago Elbit Systems posted Q4 adjusted EPS of $3.56, beating estimates by 13.4% as revenue climbed 11.3% year-over-year to $2.15 billion. CTRN Reports $0.88 Per Share Earnings; Revenue Tops Consensus Estimates 6 days ago Citi Trends posts $0.88 per share GAAP loss versus $0.18 estimate, missing by 11.5% despite revenue topping consensus by 1.3%… Atour Lifestyle Reports $0.33 Q4 EPS, Down 86.1% YoY, as Revenue Surges 33.8% to $2.79B 6 days ago Atour Lifestyle's Q4 EPS of $0.33 missed the $3.22 estimate by 89.8% despite revenue matching consensus at $2.79B, up 33.8%… TME Earnings Miss: Q4 EPS of $0.23 Falls 85.6% Short of Estimates as Revenue Plunges 83.4% 6 days ago TME's Q4 adjusted EPS of $0.23 missed estimates by 85.6% as revenue plunged 83.4% year-over-year, though net income surged to… HUYA Stock Plunges: Q4 Revenue Crashes 83.4% YoY to $248.6M, Misses EPS by 106.5% 6 days ago HUYA posts adjusted loss of $0.01 per share, missing estimates by 106.5%, as Q4 revenue plunges 83% year-over-year to $248.6… Monte Rosa (GLUE) Reports Wider Q4 Loss of $0.55/Share vs $0.34 Estimate, Revenue Misses 6 days ago Monte Rosa posts Q4 loss of $0.55/share vs $0.34 estimate, revenue of $2.8M misses $5.3M consensus by 47%. Coda Octopus (CODA) Beats Q1 Estimates with $0.08 EPS, Revenue Surges 28.6% YoY to $6.7M 6 days ago Coda Octopus posts $0.08 EPS vs $0.06 estimate; Q1 revenue of $6.7M climbs 28.6% year-over-year, topping consensus by 7.6%. Bicycle Therapeutics (BCYC) Q4 Revenue Soars 1194.5% YoY to $48M, Crushing Estimates by 578% 6 days ago Bicycle Therapeutics narrows Q4 loss to $0.29/share vs $0.95 estimate; revenue of $48M crushes $7.1M consensus by 578%. Next» « Previous